Differential Glucocorticoid Responsiveness of Hemoclialysis Patients' Lymphocytes

No abstract is available for this paper.

• Publication year

  1997

• Venue

  ASAIO journal (1992)

• Publication date

  1997-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00002480-199701000-00007PMID 9116350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation

  2004cited by this paper
• Relative immunosuppressive potency of various corticosteroids measured in vitro

  2004cited by this paper
• Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress.

  1996cited by this paper
• Differential glucocorticoid responsiveness of dialysis patients' lymphocytes.

  1996cited by this paper
• GLUCOCORTICOIDS REGULATE CALCINEURIN‐DEPENDENT TRANS‐ACTIVATING PATHWAYS FOR INTERLEUKIN‐2 GENE TRANSCRIPTION IN HUMAN T LYMPHOCYTES

  1995cited by this paper
• Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients.

  1995cited by this paper
• Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone.

  1994cited by this paper
• Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements

  1992cited by this paper
• Utility of an in vitro immunoassay to guide immunosuppressive therapy.

  1991cited by this paper
• Corticosteroid Pharmacodynamics: Models for a Broad Array of Receptor‐Mediated Pharmacologic Effects

  1990cited by this paper
• ADVERSE INFLUENCE OF RECIPIENT LYMPHOID RESISTANCE TO IN VITRO IMMUNOSUPPRESSION ON THE OUTCOME OF KIDNEY TRANSPLANTS

  1988cited by this paper
• Glucocorticoid levels and lymphocyte functions in kidney transplanted patients.

  1987cited by this paper
• THE IMPACT OF HIGH LYMPHOCYTE SENSITIVITY TO GLUCOCORTICOIDS ON KIDNEY GRAFT SURVIVAL IN PATIENTS TREATED WITH AZATHIOPRINE AND CYCLOSPORINE

  1987cited by this paper
• The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures.

  1987cited by this paper
• Variable inhibition of mitogen-induced blastogenesis in human lymphocytes by prednisolone in vitro.

  1985cited by this paper
• Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.

  1984cited by this paper
• Plasma prednisolone studies in rheumatic patients.

  1983cited by this paper
• Differential susceptibility in vitro to methylprednisolone of human lymphocyte subpopulations stimulated by phytohemagglutinin.

  1979cited by this paper

• Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine.

  2007cites this paper
• Lymphocyte Suppression by Glucocorticoids with Cyclosporine, Tacrolimus, Pentoxifylline, and Mycophenolic Acid

  1999cites this paper
• Comparison of the cytotoxic effects of corticoids on the neoplastic B cells.

  1998cites this paper